Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study.
Xu JM, Wang Y, Chen YL, Jia R, Li J, Gong JF, Li J, Qi C, Hua Y, Tan CR, Wang J, Li K, Sai Y, Zhou F, Ren YX, Qing WG, Jia H, Su WG, Shen L.
Xu JM, et al. Among authors: li j, li k.
Oncotarget. 2017 Jun 27;8(26):42076-42086. doi: 10.18632/oncotarget.14942.
Oncotarget. 2017.
PMID: 28159938
Free PMC article.
Clinical Trial.